Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI of the brain and biochemical observations in a patient with 4-hydroxybutyric aciduria; a progressive neurometabolic disease. (Q52169959)
Jump to navigation
Jump to search
scientific article published in March 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI of the brain and biochemical observations in a patient with 4-hydroxybutyric aciduria; a progressive neurometabolic disease. |
scientific article published in March 2000 |
Statements
Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI of the brain and biochemical observations in a patient with 4-hydroxybutyric aciduria; a progressive neurometabolic disease. (English)
1 reference
Al-Essa MA
1 reference
Bakheet SM
1 reference
Patay ZJ
1 reference
Powe JE
1 reference
Ozand PT
1 reference
1 March 2000
1 reference
22
1 reference
2
1 reference
127-131
1 reference